ERBB2 and breast carcinoma: MDA-MB-231 cells are characterised as ER-, PR-, and Her2/neu-negative/basal-B mammary carcinoma, while MDA-MB-468 cells are characterised as ER-, PR-, and Her2/neu-negative/basal-A mammary carcinoma [4].